WALTHAM, Mass.--(BUSINESS WIRE)--Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that Juswinder Singh, PhD, Avila’s Founder and Chief Scientific Officer, will participate in a session highlighting covalent drugs at the 241st American Chemical Society National Meeting, on Monday, March 28, 2011 in Anaheim, California.
